mtm medical | technology | marketing - products - Incontinence - Incontinence Treatment
    home    map    inprint    
You are here:  / products / Incontinence / Incontinence Treatment

Incontinence Treatment
The health insurance industry in Europe reports that 5 % of the total population suffer from temporary or continuous incontinence. A general differentiation is made between urinary(UI) and fecal (FI) incontinence. (80% / 20%).

Females constitute the majority of UI sufferers, with around 3 time greater incontinence prevalence rates than that prevalence in men. It is estimated that the prevalence of UI in women is between 10 and 30 percent.

Women with ’’Stress Urinary Incontinence\" (SUI) clinically present themselves with involuntary loss of urine during coughing, sneezing, laughing or other physical activities that increase intra-abdominal pressure. SUI is defined as urine loss coincident with an over-distended bladder. The most common cause of SUI in women is the intrinsic urethral sphincter insufficiency (ISI). In ISI, the urethral sphincter is unable to generate enough resistance to remain completely closed to retain urine in the bladder, especially during stress maneuvers. Electro-stimulation of the muscles, applied using a correct selection of stimulation parameters, will lead to an increase of muscle strength and muscle contraction.

\"Urge Incontinence” involves the involuntary loss of urine following a strong, sudden need to void caused by uninhibited bladder contractions. When these contractions are associated with a neurological disorder such as stroke, patients are diagnosed with detrusor hyperreflexia. When combined with a non-neurological condition, the condition is known as detrusor instability.
Electro Stimulation can inhibit the dysfunction of the detrusor.

\"Fecal incontinence\" is caused by the insufficiency or loss of function of anal sphincter. The treatment is similar to urinary stress incontinence.